ASCO 2023: IDH mutation and improved cognitive functions in brain tumor patients

2023-06-04 12:19:42

–

ASCO 2023

Patients with this tumor with the IDH 1 and 2 mutation improve their motor and cognitive functions, in addition to avoiding long-term relapses.

Grade 2 gliomas with a mutation in the IDH gene are malignant brain tumors that cause considerable morbidity and premature death.

1685882522
#Vorasidenib #stops #grade #glioma #surgery #delays #chemo #radium

Related posts:

Thomas Meunier's Hilarious Encounter with Igor Tudor: A Red Devil's Humorous Side
Antetokounmpo slashed 41+12+6, the Bucks won the Pacers in doubles with 7 players-Sports-中工网
“There is no longer any appetite for our profession”: exhausted, these doctors explain why they are ...
Mexico vs Chile Women's Soccer Final: Live Updates and Coverage of the 2023 Pan American Games
Respect and Fairness: Belgium Calls for Scoring Compromise in Abandoned Euro Championship Qualifier
COVID-19: increase in infections and hospitalizations to be expected this fall
Resignation of Spanish World Champions from National Team: Latest Updates and Impacts
Superstar Cristiano Ronaldo returns to Portugal for UEFA Euro Cup qualifiers

Despite Dementia, Bruce Willis Enjoys a Day at Disneyland with Wife and Children

The Conspicuous Horse Chestnut in Remagen Square: Damage, Reconstruction & Preservation Efforts

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.